Cuál es la capitalización de mercado por HPGC Renmintongtai Pharmaceutical Corporation (600829)

Capitalización de mercado por HPGC Renmintongtai Pharmaceutical Corporation (600829) es $866.39M

Ingresos de HPGC Renmintongtai Pharmaceutical Corporation (600829)

Q: Cuál es el precio por HPGC Renmintongtai Pharmaceutical Corporation (600829)

Precio por HPGC Renmintongtai Pharmaceutical Corporation (600829) es de$1.49

HPGC Renmintongtai Pharmaceutical Corporation is a pharmaceutical enterprise actively involved in the wholesale and retail distribution of diverse medicinal products across China and internationally. Its extensive product portfolio encompasses traditional Chinese medicines, herbal remedies, chemical preparations, antibiotics, biologics, biochemical drugs, medical equipment, and health-related items. The company also extends its operations to include logistics services, specifically warehousing and distribution. Additionally, it offers comprehensive hospital services covering medical treatment, scientific research, disease prevention, health promotion, rehabilitation, blood purification, and renal disease management. Through its e-commerce platform, HPGC Renmintongtai markets a broad selection of items, including Chinese and Western pharmaceuticals, traditional Chinese herbs, nutritional supplements, medical devices, cosmetics, and everyday necessities. The company maintains a significant retail presence with 319 chain stores located throughout Heilongjiang Province. Established in 1950 and headquartered in Harbin, China, HPGC Renmintongtai Pharmaceutical Corporation operates as a subsidiary of Harbin Pharmaceutical Group Co., Ltd.

Año	Ingresos	Cambiar
Not enough data for the provided dates.

Año

Ingresos

Cambiar

Not enough data for the provided dates.

Empresa	Ingresos	Diferencia de ingresos	País
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Galderma Group AG GALD.SW	-	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	$6.61B	-	IN

Empresa

Ingresos

Diferencia de ingresos

País